Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

Soley Bayraktar, Ana M. Gonzalez-Angulo, Xiudong Lei, Aman U. Buzdar, Vicente Valero, Amal Melhem-Bertrandt, Henry M. Kuerer, Gabriel N. Hortobagyi, Aysegul A. Sahin, Funda Meric-Bernstam, Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer. Cancer. ,vol. 118, pp. 2385- 2393 ,(2012) , 10.1002/CNCR.26555

M Untch, PA Fasching, GE Konecny, S Hasmueller, A Lebeau, R Kreienberg, O Camara, V Müller, A du Bois, T Kühn, E Stickeler, N Harbeck, C Höss, S Kahlert, T Beck, W Fett, K Mehta, G von Minckwitz, S. Loibl, Abstract P1-11-03: Pathological Complete Response after Neoadjuvant Chemotherapy + Trastuzumab Treatment Predicts Survival and Detects a Patient Subgroup at High Need for Improvement of Anti-HER2 Therapy. Three Year Median Follow-Up Data of the TECHNO Trial Cancer Research. ,vol. 70, ,(2010) , 10.1158/0008-5472.SABCS10-P1-11-03

H Bonnefoi, L Biganzoli, T Cufer, L Mauriac, A Hamilton, P Schaefer, M Piccart, An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer Breast Cancer Research and Treatment. ,vol. 70, pp. 55- 63 ,(2001) , 10.1023/A:1012530607649

Luca Gianni, Wolfgang Eiermann, Vladimir Semiglazov, Alexey Manikhas, Ana Lluch, Sergey Tjulandin, Milvia Zambetti, Federico Vazquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Angel Climent, Eva Ciruelos, Belén Ojeda, Mauro Mansutti, Alla Bozhok, Roberta Baronio, Andrea Feyereislova, Claire Barton, Pinuccia Valagussa, Jose Baselga, Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort. The Lancet. ,vol. 375, pp. 377- 384 ,(2010) , 10.1016/S0140-6736(09)61964-4

Stuart J. Pocock, Richard Simon, Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial Biometrics. ,vol. 31, pp. 103- 115 ,(1975) , 10.2307/2529712

Gunter von Minckwitz, Michael Untch, Eveline Nüesch, Sibylle Loibl, Manfred Kaufmann, Sherko Kümmel, Peter A. Fasching, Wolfgang Eiermann, Jens-Uwe Blohmer, Serban Dan Costa, Keyur Mehta, Jörn Hilfrich, Christian Jackisch, Bernd Gerber, Andreas du Bois, Jens Huober, Claus Hanusch, Gottfried Konecny, Werner Fett, Elmar Stickeler, Nadia Harbeck, Volkmar Müller, Peter Jüni, Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials Breast Cancer Research and Treatment. ,vol. 125, pp. 145- 156 ,(2011) , 10.1007/S10549-010-1228-X

E. Alba, J. I. Chacon, A. Lluch, A. Anton, L. Estevez, B. Cirauqui, E. Carrasco, L. Calvo, M. A. Segui, N. Ribelles, R. Alvarez, A. Sanchez-Muñoz, R. Sanchez, J. A. Lopez Garcia-Asenjo, C. Rodriguez-Martin, M. J. Escudero, J. Albanell, A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study. Breast Cancer Research and Treatment. ,vol. 136, pp. 487- 493 ,(2012) , 10.1007/S10549-012-2100-Y

Michael Untch, Sibylle Loibl, Joachim Bischoff, Holger Eidtmann, Manfred Kaufmann, Jens-Uwe Blohmer, Jörn Hilfrich, Dirk Strumberg, Peter A Fasching, Rolf Kreienberg, Hans Tesch, Claus Hanusch, Bernd Gerber, Mahdi Rezai, Christian Jackisch, Jens Huober, Thorsten Kühn, Valentina Nekljudova, Gunter von Minckwitz, Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial Lancet Oncology. ,vol. 13, pp. 135- 144 ,(2012) , 10.1016/S1470-2045(11)70397-7

Judith Hurley, Isildinha M. Reis, Steven E. Rodgers, Carmen Gomez-Fernandez, Jean Wright, Jose Pablo Leone, Rene Larrieu, Mark D. Pegram, The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients Breast Cancer Research and Treatment. ,vol. 138, pp. 783- 794 ,(2013) , 10.1007/S10549-013-2497-Y

HS Rugo, O Olopade, A DeMichele, L van 't Veer, M Buxton, N Hylton, D Yee, AJ Chien, A Wallace, J Lyandres, S Davis, A Sanil, D Berry, L Esserman, , Abstract S5-02: Veliparib/carboplatin plus standard neoadjuvant therapy for high-risk breast cancer: First efficacy results from the I-SPY 2 TRIAL Cancer Research. ,vol. 73, ,(2013) , 10.1158/0008-5472.SABCS13-S5-02